Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds

Overview of attention for article published in Malaria Journal, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter: 36 X users

patent: 1 patent

Citations

dimensions_citation: 68 Dimensions

Readers on

mendeley: 86 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 68 publications that cite this research output.

68

The most recent citing publications are shown below. View all 68 publications that cite this research output on Dimensions.

Cytochrome P450 2D6 profiles and anti-relapse efficacy of tafenoquine against Plasmodium vivax in Australian Defence Force personnel

Article in Antimicrobial Agents and Chemotherapy (November 2023)

The role of P450 enzymes in malaria and other vector‐borne infectious diseases

Article in BioFactors (August 2023)

Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review

Article in Infectious Diseases and Therapy (November 2022)